|Bid||0.0540 x 0|
|Ask||0.0490 x 0|
|Day's Range||0.0520 - 0.0670|
|52 Week Range||0.0170 - 0.0940|
|Beta (3Y Monthly)||-1.78|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 1, 2016 - Mar 5, 2016|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! If you own shares in Antisense Therapeutics Limited (ASX:ANP) thenRead More...
Mark Diamond has been the CEO of Antisense Therapeutics Limited (ASX:ANP) since 2001. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, Read More...
Every investor in Antisense Therapeutics Limited (ASX:ANP) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often Read More...